BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jonsson B, Liljas A. Comments to the Editor Due to the Response by the Supuran Group to Our Article. Biophysical Journal 2021;120:182-3. [DOI: 10.1016/j.bpj.2020.11.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Nocentini A, Angeli A, Carta F, Winum JY, Zalubovskis R, Carradori S, Capasso C, Donald WA, Supuran CT. Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase. J Enzyme Inhib Med Chem 2021;36:561-80. [PMID: 33615947 DOI: 10.1080/14756366.2021.1882453] [Cited by in Crossref: 34] [Cited by in F6Publishing: 44] [Article Influence: 34.0] [Reference Citation Analysis]
2 Nocentini A, Capasso C, Supuran CT. Small-molecule CD73 inhibitors for the immunotherapy of cancer: a patent and literature review (2017-present). Expert Opin Ther Pat 2021;:1-10. [PMID: 33909515 DOI: 10.1080/13543776.2021.1923694] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]